A5032269053- Liver Disease Diagnosis and Treatment
- Gallbladder and Bile Duct Disorders
- Liver Disease and Transplantation
- Hepatitis C virus research
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Hepatitis B Virus Studies
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Diseases and Immunity
- Pancreatitis Pathology and Treatment
- Pediatric Hepatobiliary Diseases and Treatments
- Esophageal and GI Pathology
- Gastric Cancer Management and Outcomes
- Diet, Metabolism, and Disease
- Helicobacter pylori-related gastroenterology studies
- Gastrointestinal disorders and treatments
- Esophageal Cancer Research and Treatment
- Cancer, Lipids, and Metabolism
- Gastrointestinal Bleeding Diagnosis and Treatment
- Gastroesophageal reflux and treatments
- Organ Transplantation Techniques and Outcomes
- Diverticular Disease and Complications
- Bariatric Surgery and Outcomes
- Inflammatory Bowel Disease
- Alcohol Consumption and Health Effects
Yale University
2016-2025
VA Connecticut Healthcare System
2017-2025
United States Department of Veterans Affairs
2024
Baton Rouge General
2024
Brookdale University Hospital and Medical Center
2024
Montefiore Medical Center
2024
Brown University
2024
Mount Sinai Health System
2024
Richmond University Medical Center
2024
University of Chicago
2024
The rise in incidence of hepatocellular carcinoma (HCC) the United States has been well documented. purpose this analysis was to examine temporal trends HCC incidence, mortality, and survival within U.S. population. Surveillance, Epidemiology, End Results data were used incidence-based (IB) mortality from 1973 2011. Secular age-adjusted IB by sex cancer stage characterized using Joinpoint Regression program. In 1973, 1.51 cases per 100,000, whereas 2011, 6.20 100,000. Although continues...
The rise in incidence of esophageal cancer (EC) the USA over last four decades has been well documented; however, data on trends long-term survival and impact modern therapies associated with are lacking.The Surveillance, Epidemiology, End Results database was queried to identify patients confirmed EC. Cox proportional hazard regression used determine independent mortality factors.Of 93 167 diagnosed EC between 1973 2009, 49% had a histologic diagnosis adenocarcinoma (EAC). There an increase...
Concerns related to hepatotoxicity frequently lead discontinuation or non-initiation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase therapy in patients with cirrhosis despite data supporting statin use. We investigated the independent effects hyperlipidemia and exposure on mortality, hepatic decompensation, hepatocellular carcinoma development a large national cohort cirrhosis.We performed retrospective study newly diagnosed from January 1, 2008 through June 30, 2016 Veterans Health...
Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide. Several types chronic liver disease predispose to HCC, and several different signalling pathways have been implicated in its pathogenesis, but no common molecular event has identified. Ca
Abstract Early identification of high-risk metabolic dysfunction-associated steatohepatitis (MASH) can offer patients access to novel therapeutic options and potentially decrease the risk progression cirrhosis. This study aimed develop an explainable machine learning model for MASH prediction compare its performance with well-established biomarkers. Data were derived from National Health Nutrition Examination Surveys (NHANES) 2017-March 2020, which included a total 5281 adults valid...
Early transjugular intrahepatic portosystemic shunt (TIPS) used as preventive therapy prior to recurrent bleeding has been recommended in patients presenting with acute esophageal variceal (EVB) who are at high risk of further and death. We investigated the impact early TIPS on outcomes US hospitalized EVB from 2000 2010.The Nationwide Inpatient Sample database was queried identify decompensated cirrhosis (because is only high-risk patients). The primary outcome in-hospital death, secondary...